Early trial tests supercharged immune cells against tough lymphoma
Disease control
Recruiting now
This early-phase study is testing the safety and initial effectiveness of a new type of CAR-T cell therapy for adults with an aggressive form of lymphoma that has come back or not responded to at least two prior treatments. The therapy involves collecting a patient's own immune c…
Phase: EARLY_PHASE1 • Sponsor: He Huang • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC